Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma

Cancer Research

Volumn 56, Issue 9, 1996, Pages 2167-2170

  Eng, Charis ^a,b,f   Mulligan, Lois M ^c   Healey, Catherine S ^a   Houghton, Carol ^a   Frilling, Andrea ^d   Raue, Friedhelm ^e   Thomas, Gerry A ^a   Ponder, Bruce A J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL SUBPOPULATION; CODON; GENE MUTATION; GENETIC HETEROGENEITY; GERM LINE; HUMAN; HUMAN TISSUE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; PROTEIN FAMILY; PROTO ONCOGENE; RECEPTOR GENE; SOMATIC MUTATION; THYROID MEDULLARY CARCINOMA;

CARCINOMA, MEDULLARY; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 22; DROSOPHILA PROTEINS; HUMANS; MUTATION; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0029944584     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Schimke, R. N. Genetic aspects of multiple endocrine neoplasia. Annu Rev. Med., 35 25-31, 1984
2. Mulligan, L M , Marsh, D. J , Robinson, B. G , Schuffenecker, I , Zedenius, J., Lips, C J M., Gagel, R. F , Takai, S-I., Noll, W W., Fink, M., Raue, F., Lacroix, A., Thibodeau, S. N , Frilling, A , Ponder, B. A. J., and Eng, C. Genotype-phenotype correlation in MEN 2: report of the International RET Mutation Consortium J Intern. Med., 238: 343-346, 1995.
3. Santoro, M., Rosato, R , Grieco, M , Berlingieri, M. T., Luca-Colucci D'Amato, G., de Franciscis, V , and Fusco, A. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene, 5: 1595-1598, 1990.
4. Nakamura, T., Ishizaka, Y , Nagao, M , Hara, M., and Ishikawa, T Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J. Pathol., 172: 255-260, 1994.
5. Mulligan, L. M., Kwok, J. B J., Healey, C. S , Elsdon, M. J., Eng, C , Gardner, E., Love, D R., Mole, S. E., Moore, J. K., Papi, L , Ponder, M. A , Telenius, H , Tunnacliffe, A , and Ponder, B. A. J. Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (Lond), 363: 458-460, 1993
6. Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K , Lairmore, T. C., Howe, J. R., Moley, J F., Goodfellow, P , and Wells . S. A. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. Mol. Genet , 2: 851-856, 1993
7. Mulligan, L. M., Eng, C., Healey, C. S., Clayton, D., Kwok, J. B. J , Gardner, E., Ponder, M. A., Frilling, A., Jackson, C. E., Lehnert, H., Neumann, H. P. H., Thibodeau, S N., and Ponder, B. A. J Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat. Genet., 6: 70-74, 1994
8. Mulligan, L M., Eng, C., Healey, C. S , Ponder, M. A., Feldman, G. L., Li, P , Jackson, C. E., and Ponder, B. A. J. A de novo mutation of the RET proto-oncogene in a patient with MEN 2A. Hum. Mol. Genet., 3, 1007-1008, 1994.
9. Santoro, M., Carlomagno, F., Romano, A., Bottaro, D P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H , and Di Fiore, P P. Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B Science (Washington DC), 267: 381-383, 1995.
10. Eng, C., Smith, D. P., Mulligan, L. M , Healey, C. S , Zvelebil, M. J., Stonehouse, T. J., Ponder, M A., Jackson, C. E., Waterfield, M. D , and Ponder, B. A. J. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene. 10: 509-513, 1995.
11. Bolino, A., Schuffenecker, I., Luo, Y., Seri, M., Silengo, M , Tocco, T., Chabrier, G , Houdent, C., Murat, A., Schlumberger, M., Toumiaire, J., Lenoir, G M., and Romeo, G. RET mutations in exons 13 and 14 of FMTC patients. Oncogene, 10: 2415-2419, 1995
12. Hofstra, R. M W , Landsvater, R. M., Ceccherini, I , Stulp, R. P., Steelwagen, T., Luo, Y., Pasini, B., Hoppener, J. W. M., Ploos van Amstel, H. K., Romeo, G., Lips, C. J. M , and Buys, C. H. C. M A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma Nature (Lond.), 367 375-376, 1994.
13. Eng, C., Smith, D. P., Mulligan, L. M., Nagai, M. A., Healey, C. S., Ponder, M A , Gardner, E , Scheumann, G. F. W., Jackson, C. E., Tunnacliffe, A , and Ponder, B. A. J. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours Hum. Mol Genet., 3, 237-241, 1994.
14. Carlson, K. M , Dou, S., Chi, D., Scavarda, N., Toshima, K., Jackson, C. E., Wells, S. A., Goodfellow, P. J., and Donis-Keller, H. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc. Natl. Acad. Sci. USA, 91, 1579-1583, 1994.
15. Songyang, Z , Carraway, K L., III, Eck, M J., Harrison, S. C., Feldman, R. A., Mohammadi, M , Schlessinger, J., Hubbard, S. R., Smith, D P., Eng, C., Lorenzo, M. J., Ponder, B. A. J., Mayer, B. J., and Cantley, L C. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature (Lond.), 373. 536-539, 1995.
16. Mulligan, L M., Gardner, E., Smith, B. A., Mathew, C. G. P., and Ponder, B. A. J Genetic events in tumor initiation and progression in multiple endocrine neoplasia Genes Chromosomes &. Cancer, 6. 166-177, 1993
17. Eng, C., and Ponder, B. A. J. The role of gene mutations in the genesis of familial cancers. FASEB J , 7, 910-919, 1993.
18. Zedenius, J., Wallin, G., Hamberger, B., Nordenskjold, M., Weber, G., and Larsson. C. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTCs. Hum. Mol. Genet., 3, 1259-1262, 1994.
19. Eng, C , Mulligan, L. M., Smith, D P., Healey, C. S., Frilling, A., Raue, F., Neumann, H. P. H., Pfragner, R., Behmel, A., Lorenzo, M. J., Stonehouse, T. J., Ponder, M A., and Ponder, B. A J. Mutation of the RET proto-oncogene in sporadic medullary thyroid carcinoma Genes Chromosomes & Cancer. 12, 209-212, 1995
20. Kommmoth, P , Kunz, E K , Matias-Guiu, X., Hiort, O., Christensen, G., Colomer, A., Roth, J., and Heitz, P. U. Analysis of RET proto-oneogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. Cancer (Phila.), 76, 479-489, 1995.
21. Wright, D. K., and Manos, M. Sample preparation from paraffin-embedded tissues. In: M. A. Innis, D H. Gelfand, J. J. Sninsky, and T. J White (eds.), PCR Protocols A Guide to Methods and Application, pp. 153-158. San Diego. Harcourt Brace Jovanovich Publications, 1990.
22. Marsh, D. J., Learoyd, D. L., Andrew, S. D , Krishnan, L., Pojer, R., Richardson, A-L., Delbridge, L , Eng, C , and Robinson, B G. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Clin. Endocrinol (Oxf.), 44: 249-257, 1996
23. Kwok, J. B. J., Gardner, E , Warner, J. P., Ponder, B. A. J., and Mulligan, L. M. Structural analysis of the human ret proto-oncogene by exon trapping. Oncogene, 3: 2572-2582, 1993.
24. Gyapay, G , Morissette, J , Vignal, A., Dib, C , Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M., and Weissenbach, J. The 1993-94 Généthon human genetic linkage map. Nat Genet , 7: 246-339, 1994
25. Love, D. R., Gardner, E., and Ponder, B. A. J A polymorphic dinucleotide repeat at DI0S141 locus Hum. Mol. Genet , 2: 491, 1993.
26. Love. D. R., Gardner, E , and Ponder, B. A. J. A polymorphic dinucleotide repeat at the ZNF22 locus Hum. Mol. Genet , 2 491, 1993.
27. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1992.
28. Blaugrund, J. E , Johns, M. M , Eby, Y. J., Ball, D. W., Baylin, S. B , Hruban, R H , and Sidranstcy, D. RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Hum Mol Genet., 3, 1895-1897, 1994
29. Borrello, M. G , Smith, D. P., Pasini, B , Bongarzone, I., Greco, A., Lorenzo, M J., Arighi, E , Miranda, C , Eng, C , Alberti, L., Bocciardi, R. P M , Scopsi, L., Romeo, G., Ponder, B. A. J , and Pierotti, M A RET activation by germline MEN2A and MEN2B mutations. Oncogene, in press, 1996.
30. Marsh, D. J., Andrew, S D , Eng, C., Learoyd, D L , Capes, A G , Pojer, R., Richardson, A-L , Houghton, C., Mulligan, L M, Ponder, B. A. J., and Robinson. B. G Germline and somatic mutations in an oncogene. RET mutations in inherited medullary thyroid carcinoma. Cancer Res., 56: 1241-1243, 1996.